US 11,684,720 B2
Antiseptic cap that releases a gas such as nitric oxide
William Anderson, Cary, IL (US); Mark Wilson, Rochester, NY (US); Gary Henniger, Belmar, NJ (US); Larry Colquitt, West Henrietta, NY (US); Christopher E. Gardner, Manalapan, NJ (US); and Chirag S. Walawalkar, Jackson, NJ (US)
Assigned to Excelsior Medical Corporation, San Clemente, CA (US)
Filed by Excelsior Medical Corporation, San Clemente, CA (US)
Filed on Aug. 24, 2022, as Appl. No. 17/822,074.
Application 17/822,074 is a continuation of application No. 17/576,842, filed on Jan. 14, 2022.
Application 17/576,842 is a continuation of application No. 16/418,365, filed on May 21, 2019, granted, now 11,229,746, issued on Jan. 25, 2022.
Application 16/418,365 is a continuation of application No. 15/637,998, filed on Jun. 29, 2017, granted, now 10,328,207, issued on Jun. 25, 2019.
Application 15/637,998 is a continuation of application No. 14/799,022, filed on Jul. 14, 2015, granted, now 9,707,350, issued on Jul. 18, 2017.
Application 14/799,022 is a continuation of application No. 13/547,650, filed on Jul. 12, 2012, granted, now 9,259,535, issued on Feb. 16, 2016.
Application 13/547,650 is a continuation in part of application No. 13/288,529, filed on Nov. 3, 2011, granted, now 9,700,710, issued on Jul. 11, 2017.
Application 13/288,529 is a continuation in part of application No. 12/214,526, filed on Jun. 19, 2008, granted, now 9,707,348, issued on Jul. 18, 2017.
Application 12/214,526 is a continuation in part of application No. 11/821,190, filed on Jun. 22, 2007, granted, now 8,167,847, issued on May 1, 2012.
Application 12/214,526 is a continuation in part of application No. 11/821,190, filed on Jun. 22, 2007, granted, now 8,167,847, issued on May 1, 2012.
Claims priority of provisional application 60/815,806, filed on Jun. 22, 2006.
Prior Publication US 2022/0401652 A1, Dec. 22, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 5/315 (2006.01); A61M 5/31 (2006.01); A61M 25/04 (2006.01); A61M 39/02 (2006.01); A61M 39/16 (2006.01); A61M 39/20 (2006.01); A61M 5/00 (2006.01); A61M 5/34 (2006.01); A61M 25/00 (2006.01); A61M 39/10 (2006.01)
CPC A61M 5/31511 (2013.01) [A61M 5/31 (2013.01); A61M 25/04 (2013.01); A61M 39/02 (2013.01); A61M 39/16 (2013.01); A61M 39/162 (2013.01); A61M 39/20 (2013.01); A61M 5/001 (2013.01); A61M 5/002 (2013.01); A61M 5/3135 (2013.01); A61M 5/3137 (2013.01); A61M 5/31513 (2013.01); A61M 5/347 (2013.01); A61M 2005/3104 (2013.01); A61M 2005/31506 (2013.01); A61M 2025/0019 (2013.01); A61M 2039/1033 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An antiseptic medical cap comprising:
a base comprising a proximal surface and a distal surface;
a sidewall extending in a distal direction from the base, the sidewall comprising a proximal end and a distal end;
a chamber configured to receive a proximal end of a medical fluid port having an opening; and
an insert comprising a gas-releasing anti-microbial compound, the insert extending in the distal direction, the insert being configured to be positioned at least partially through the opening of the medical fluid port when the antiseptic medical cap receives the proximal end of the medical fluid port into the chamber.